Extracellular ATP (eATP) inhibits the progression of endometriosis and enhances the immune function of macrophages
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
Extracellular ATP administration was found to inhibit endometriosis progression and enhance macrophage immune function in this study.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Extracellular adenosine triphosphate (eATP) is an important inflammatory mediator that can boost the antitumour immune response, but its role in endometriosis remains unknown. We hypothesized that eATP could inhibit endometriosis cell function both directly and indirectly through macrophages.
METHODS: Peritoneal and cyst fluid from endometriosis patients and non-endometriosis controls was collected to measure eATP levels. The addition of eATP was performed to explore its effects on endometriotic cell and macrophage functions, including cell proliferation, apoptosis, pyroptosis, mitochondrial membrane potential, phagocytosis, and the production of inflammatory cytokines and reactive oxygen species. A coculture of endometriotic epithelial cells and U937 macrophages was established, followed by P2X7 antagonist and eATP treatment. Endometriosis model eATP-treated rats were used to evaluate in situ cell death and macrophage marker expression.
RESULTS: The pelvic microenvironment of endometriosis patients shows high eATP levels, which could induce endometriotic epithelial cell apoptosis and pyroptosis and significantly inhibit cell growth via the MAPK/JNK/Akt pathway. eATP treatment ameliorated endometriosis-related macrophage dysfunction and promoted macrophage recruitment. eATP treatment in the presence of macrophages exerted a stronger cytotoxic effect on endometriotic epithelial cells by regulating P2X7. eATP treatment effectively induced cell death in an endometriosis rat model and prominently increased the macrophage number without affecting the eutopic endometrium.
CONCLUSION: eATP induces endometriotic epithelial cell death and enhances the immune function of macrophages to inhibit the progression of endometriosis, while eutopic endometrium is not affected. eATP treatment may serve as a nonhormonal therapeutic strategy for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (72)
- Adenosine Triphosphate Regresses Endometrial Explants in a Rat Model of Endometriosis via openalex
- Anti-inflammatory cytokines in endometriosis via openalex
- An update on the pharmacological management of endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology via openalex
- Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis via openalex
- Endometrial stromal cells treated by tumor necrosis factor‐α stimulate macrophages polarized toward M2 via interleukin‐6 and monocyte chemoattractant protein‐1 via openalex
- Endometriosis and Cancer: Exploring the Role of Macrophages via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Estrogen is an important mediator of mast cell activation in ovarian endometriomas via openalex
- Estrogen-regulated CD200 inhibits macrophage phagocytosis in endometriosis via openalex
- Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP‐α in peritoneal macrophages via openalex
- Identification of Biomarkers for Endometriosis Using Clinical Proteomics via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Macrophages alternatively activated by endometriosis-exosomes contribute to the development of lesions in mice via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Pathogenesis of endometriosis: the genetic/epigenetic theory via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β via openalex
- The Pains of Endometriosis via openalex
- The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval via openalex
- Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls via openalex
- Villainous role of estrogen in macrophage-nerve interaction in endometriosis via openalex
- W2810947153 via openalex
- W2906877570 via openalex
- W2909832174 via openalex
- W2938892895 via openalex
- W2948438687 via openalex
- W2950884881 via openalex
- W2951509935 via openalex
- W2969420549 via openalex
- W2978057557 via openalex
- W2984141991 via openalex
- W3040488015 via openalex
- W3041764348 via openalex
- W3089815098 via openalex
- W3119876112 via openalex
- W3164312167 via openalex
- W3215450254 via openalex
- W4200587689 via openalex
- W4211081176 via openalex
- W4224131520 via openalex
- W4294183732 via openalex
- W4296146232 via openalex
- W6640754151 via openalex
- W6788882615 via openalex
- W1864325817 via openalex
- W1971915082 via openalex
- W1999998145 via openalex
- W2070663123 via openalex
- W2084007114 via openalex
- W2088147605 via openalex
- W2102219008 via openalex
- W2112810110 via openalex
- W2129388928 via openalex
- W2149371927 via openalex
- W2175794645 via openalex
- W2289461953 via openalex
- W2301044272 via openalex
- W2555319670 via openalex
- W2566472201 via openalex
- W2613266840 via openalex
- W2737555531 via openalex
- W2754055756 via openalex
- W2757289584 via openalex
- W2779261291 via openalex
- W2788640168 via openalex
- W2793479725 via openalex
- W2793830223 via openalex
- W2801598991 via openalex
Cited by (6)
- Glycolytic reprogramming in endometriosis: molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities 2026
- Molecular Insights Into Endometriosis for Early Detection and Therapeutic Targets 2026
- The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia 2025
- Endometriosis and autoimmunity 2025
- ATP/P2X4 Regulates Inflammation and Oxidative Stress in Endometriosis Through NLRP3 Inflammasome-Dependent Mechanisms 2025
- Regulated Cell Death in Endometriosis 2024
Source provenance
- europepmc
- last seen: 2026-08-18T06:10:16.649438+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-08-18T06:09:05.803551+00:00
- unpaywall
- last seen: 2026-08-18T06:27:49.008893+00:00
License: CC0
· commercial use OK